EUVIMEDEUVIMED entdecken
Querschnittstudie

Nicotine Exposure and Cancer Risk Potential From Smokeless Tobacco (Nasvay) in Uzbekistan: A Cross-Sectional Product and Comparative Analysis

Jasur Juraev, Zhaoqing Lyu, Menglin Fan, Shuxrat Shukurov, Rustam Yuldashev, Azamjon Toshpulatov, Anvarjon Rakhimov, Sherzad Tuychiev, Tayzar Tun, Jamolkhon Kayumov, Odiljon Mirzamukhamedov, Shomurod Rasulov und 1 weitere

JCO Global Oncology · 01.11.2026 · 12 (Supplement_1) · 11-11

DOI: 10.1200/go-26-18000 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift JCO Global Oncology, erschienen am 01.11.2026. Verfasst von Jasur Juraev und 12 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Smokeless tobacco use remains widespread in Central Asia, particularly in the form of nasvay in Uzbekistan. Despite its established association with oral and gastrointestinal cancers, quantitative data on nicotine exposure and potential health risks are limited. This study aimed to assess regional variability in nicotine concentrations of nasvay products and to estimate exposure levels relevant to cancer risk. METHODS A cross-sectional product analysis was conducted using 25 nasvay samples collected from six regions of Uzbekistan. Nicotine concentrations were measured using gas chromatography–mass spectrometry (GC–MS). Comparative data for cigarettes sold in China were obtained from published laboratory studies. Estimated daily intake (EDI) and hazard quotient (HQ) were calculated under multiple exposure scenarios based on frequency of use (5 and 10 times/day) and absorption rates (60% and 100%), assuming a 60 kg adult body weight. RESULTS Nicotine concentrations in nasvay ranged from 2.07 to 15.66 mg/g, substantially higher than in cigarettes (0.8 mg/g). Tashkent city showed significantly elevated nicotine levels compared with cigarettes (p = 0.032; r = 0.78). Under moderate use (5 times/day), EDI ranged from 0.160 to 3.132 mg/kg/day (60% absorption), with HQ values of 200–3915. Under heavy use (10 times/day), HQ values increased markedly, reaching 400–7830 (60%) and up to 13,050 under maximum exposure assumptions. All scenarios exceeded the safety threshold (HQ > 1) by several orders of magnitude. CONCLUSION Nasvay products in Uzbekistan deliver high and highly variable nicotine doses, resulting in substantial exposure and elevated potential health risks. Given the established link between smokeless tobacco use and cancer, these findings highlight an urgent need for regulatory oversight, standardized product monitoring, and targeted cancer prevention strategies in Central Asia.

Zitieren

APA

Juraev, J., Lyu, Z., Fan, M., Shukurov, S., Yuldashev, R., Toshpulatov, A., Rakhimov, A., Tuychiev, S., Tun, T., Kayumov, J., Mirzamukhamedov, O., Rasulov, S., & Harada, K. (2026). Nicotine Exposure and Cancer Risk Potential From Smokeless Tobacco (Nasvay) in Uzbekistan: A Cross-Sectional Product and Comparative Analysis. JCO Global Oncology, 12(Supplement_1), 11-11. https://doi.org/10.1200/go-26-18000

Vancouver

Juraev J, Lyu Z, Fan M, Shukurov S, Yuldashev R, Toshpulatov A, et al. Nicotine Exposure and Cancer Risk Potential From Smokeless Tobacco (Nasvay) in Uzbekistan: A Cross-Sectional Product and Comparative Analysis. JCO Global Oncology. 2026;12(Supplement_1):11-11. doi:10.1200/go-26-18000

BibTeX
@article{Juraev2026,
  author = {Juraev, Jasur and Lyu, Zhaoqing and Fan, Menglin and Shukurov, Shuxrat and Yuldashev, Rustam and Toshpulatov, Azamjon and Rakhimov, Anvarjon and Tuychiev, Sherzad and Tun, Tayzar and Kayumov, Jamolkhon and Mirzamukhamedov, Odiljon and Rasulov, Shomurod and Harada, Kouji},
  title = {Nicotine Exposure and Cancer Risk Potential From Smokeless Tobacco (Nasvay) in Uzbekistan: A Cross-Sectional Product and Comparative Analysis},
  journal = {JCO Global Oncology},
  year = {2026},
  volume = {12},
  number = {Supplement_1},
  pages = {11--11},
  doi = {10.1200/go-26-18000}
}
Kostenlos starten →